Manila Doctors Hospital, simply referred to as MaDocs, is a tertiary hospital located in Ermita, Manila, Philippines with over 500 beds. It was founded in the City of Manila in 1956 by the group of doctors. The hospital is currently owned by the Manila Medical Services, Inc. and the Metrobank Foundation.

During the past decade, Manila Doctors Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 12 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Manila Doctors Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Clover Biopharmaceuticals AUS Pty Ltd" with 2 trials sponsored and "Agennix" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Manila Doctors Hospital" #1 collaborator was "ATTRaCT program by A*STAR BMRC Singapore" with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Manila Doctors Hospital" are "COVID-19" (2 trials), "Brain Ischemia" (1 trials), "Caloric Deficit" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "Manila Doctors Hospital" in a lesser frequency.

Most popular intervention types in "Manila Doctors Hospital" are "Drug" (17 trials), "Biological" (5 trials), "Combination Product" (2 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pregabalin Dose Level 1" (2 trials), "Pregabalin Dose Level 2" (2 trials), "ATM-AVI" (1 trials) and "Acalabrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Manila Doctors Hospital" are 20 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Manila Doctors Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Manila Doctors Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Manila Doctors Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".